Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A research center's experience of T-cell redirecting therapies in triple-class refractory multiple myeloma.
Puertas B, Fernández-Sánchez A, Alejo E, Rey-Bua B, Martín-López AÁ, Pérez López E, Lopez-Parra M, Lopez-Corral L, Gutierrez NC, García-Sanz R, Puig N, Gonzalez-Calle V, Mateos MV. Puertas B, et al. Among authors: rey bua b. Blood Adv. 2024 May 8:bloodadvances.2024012773. doi: 10.1182/bloodadvances.2024012773. Online ahead of print. Blood Adv. 2024. PMID: 38717869
Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients.
Puertas B, González-Calle V, Sureda A, Moreno MJ, Oriol A, González E, Rosiñol L, López J, Escalante F, Martínez-Lopez J, Carrillo E, Clavero E, Ríos-Tamayo R, Rey-Bua B, González-Rodríguez AP, Dourdil V, De Arriba F, González S, Pérez-de-Oteyza J, Hernández MT, García-Mateo A, Bargay J, Bladé J, Lahuerta JJ, San Miguel JF, Ocio EM, Mateos MV. Puertas B, et al. Among authors: rey bua b. Haematologica. 2023 Oct 1;108(10):2753-2763. doi: 10.3324/haematol.2022.282490. Haematologica. 2023. PMID: 37102598 Free PMC article. Clinical Trial.
Multiple myeloma with t(11;14): impact of novel agents on outcome.
Puertas B, González-Calle V, Sobejano-Fuertes E, Escalante F, Rey-Bua B, Padilla I, García-Sanz R, Puig N, Gutiérrez NC, Mateos MV. Puertas B, et al. Among authors: rey bua b. Blood Cancer J. 2023 Mar 20;13(1):40. doi: 10.1038/s41408-023-00807-9. Blood Cancer J. 2023. PMID: 36935422 Free PMC article.
Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma.
Puertas B, González-Calle V, Sobejano-Fuertes E, Escalante F, Queizán JA, Bárez A, Labrador J, Alonso-Alonso JM, García de Coca A, Cantalapiedra A, Villaescusa T, Aguilar-Franco C, Alejo-Alonso E, Rey-Bua B, López-Corral L, García-Sanz R, Puig N, Gutiérrez NC, Mateos MV. Puertas B, et al. Among authors: rey bua b. Cancers (Basel). 2023 Mar 2;15(5):1558. doi: 10.3390/cancers15051558. Cancers (Basel). 2023. PMID: 36900349 Free PMC article.
Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups.
Rey-Búa B, Cabrero M, Bento L, Montoro J, Bastos-Oreiro M, Parody R, Yañez L, Lopez-Godino O, Zanabili J, Herrera P, Gutierrez G, Perez A, Piñana JL, Novelli S, Cortés M, Sureda AM, Caballero D, García-Sancho AM. Rey-Búa B, et al. Cancers (Basel). 2022 Nov 18;14(22):5670. doi: 10.3390/cancers14225670. Cancers (Basel). 2022. PMID: 36428762 Free PMC article.
Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD.
Vilorio-Marqués L, Castañón Fernández C, Mora E, Gutiérrez L, Rey Bua B, Jiménez Lorenzo MJ, Díaz Beya M, Vara Pampliega M, Molero A, Sánchez-García J, Calabuig M, Cedena MT, Chen-Liang T, Díaz Santa JA, Padilla I, Hernández F, Díez R, Asensi P, Xicoy B, Sanz G, Valcárcel D, Diez-Campelo M, Bernal T. Vilorio-Marqués L, et al. Among authors: rey bua b. Ther Adv Hematol. 2022 Sep 29;13:20406207221127547. doi: 10.1177/20406207221127547. eCollection 2022. Ther Adv Hematol. 2022. PMID: 36199837 Free PMC article.
Multiple myeloma with chronic kidney disease dependent on peritoneal dialysis and autologous stem cell transplant.
Tyszkiewicz A, Heras Benito M, Urzola Rodriguez G, Rey Búa B, Baile González M, Sánchez-Jáuregui Castillo M. Tyszkiewicz A, et al. Among authors: rey bua b. Nefrologia (Engl Ed). 2022 Jan-Feb;42(1):108-109. doi: 10.1016/j.nefroe.2022.03.002. Epub 2022 Mar 16. Nefrologia (Engl Ed). 2022. PMID: 36153892 Free article. No abstract available.
Multiple myeloma with chronic kidney disease dependent on peritoneal dialysis and autologous stem cell transplant.
Tyszkiewicz A, Heras Benito M, Urzola Rodriguez G, Rey Búa B, Baile González M, Sánchez-Jáuregui Castillo M. Tyszkiewicz A, et al. Among authors: rey bua b. Nefrologia (Engl Ed). 2020 Nov 24:S0211-6995(20)30168-5. doi: 10.1016/j.nefro.2020.07.014. Online ahead of print. Nefrologia (Engl Ed). 2020. PMID: 33246783 Free article. English, Spanish. No abstract available.